$Phunware(PHUN)$ Phunware jumps 17% premarket after Trump's rival withdrew from the election
分享一些不入流的股票资讯
$Phunware(PHUN)$ Phunware jumps 17% premarket after Trump's rival withdrew from the election
$Fisker Inc(FSR)$ Fisker jumps 16% premarket after expecting to sell all its remaining 2023 vehicles
$Bit Brother(BETS)$ Bit Brother climbs 16% premarket after requesting immediate withdrawal of its registration statement on form S-3
$Vroom(VRM)$ Vroom plunges 48% premarket after the company announced it is discontinuing its operations and winding down its used vehicle dealership business
$B. Riley Financial(RILY)$ B. Riley Financial slumps 19% premarket after SEC probed the Co.'s deals with client tied to failed hedge fund
$Coherus生物科技(CHRS)$ Coherus BioSciences jumps 28% premarket as Sandoz to acquire the Co.
$DatChat(DATS)$ DatChat, Inc. plunges 39% after announcing proposed underwritten public offering of common stock
$Remark控股(MARK)$ Remark Holdings drops 27% as Australia considered putting up mandatory guardrails on AI
$Transphorm(TGAN)$ Transphorm surges 30% premarket after shareholders approved Reneseas' acquisition
$LumiraDx(LMDX)$ LumiraDx plunges 29% premarket after announcing its securities will be suspended from trading on Nasdaq
$Cellectar(CLRB)$ Cellectar BioSciences surges 52% premarket after announcing Positive topline data achieving primary endpoint in pivotal clinical study of Iopofosine I 131 in Waldenstrom’s macroglobulinemia
$Axonics(AXNX)$ Boston Scientific to buy Axonics Inc for $71 per share in cash.
$Axonics(AXNX)$ Axonics, Boston Scientific see deal close in first half of 2024.
$达达(DADA)$ JD unit Dada Nexus identified suspicious practices in audit.
$The Arena Group(AREN)$ The Arena Group Holdings suges 33% premarket after reporting a new buyout offer for the company
$SELLAS生命科学(SLS)$ SELLAS Life Sciences slumps 28% premarket after announcing intends to launch public offering of common stock and warrants
$Mobileye(MBLY)$ Mobileye Global plunges 20% premarket after expecting that Q1 2024 REV will be significantly below first Qtr 2023 Rev
$Omega Therapeutics(OMGA)$ Omega Therapeutics rockets 103% premarket on research pact with Novo Nordisk
$Rapid Micro(RPID)$ Rapid Micro Biosystems surges 25% premarket after Samsung Biologics selected the Co.'s Growth Direct Platform
$Cibus(CBUS)$ Cibus(Ticker: CBUS) has surged to $20.47 and up more than 100.10% since its Dec 12 low.